17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC)
7
17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC) Kuala Lumpur, Malaysia Chair: Nicholas Paton
description
17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC) Kuala Lumpur, Malaysia Chair: Nicholas Paton. OPENING REMARKS. Dr. Nicholas Paton Singapore. Agenda. Disclosures. - PowerPoint PPT Presentation
Transcript of 17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC)
17:00 – 19:00 | Sunday, 30 June, 2013
Session Room 3Kuala Lumpur Convention Centre (KLCC)Kuala Lumpur, Malaysia
Chair: Nicholas Paton
OPENING REMARKS
Dr. Nicholas Paton
Singapore
3
Agenda
17:00–17:05 Opening Remarks Nicholas Paton,Singapore
17:05–17:35 Cryptococcal meningitis and tuberculosis Andrew Kambugu, Uganda
17:35–18:05 HIV-associated neurocognitive disorder (HAND) Patrick Li, Hong Kong
18:05–18:35 Hepatitis B and C Jürgen Rockstroh, Germany
18:35–18:50 Discussion / Q&A Panel
18:50–19:00 Closing Remarks Nicholas Paton, Singapore
4
Disclosures
Speakers have acted as advisor, received speaker fees/meeting expenses, or received research grants/drug support from:
• Dr. Nicholas Paton: Abbott, AbbVie, Genentech, Gilead, GSK, Janssen diagnostics, Merck, Pfizer
• Dr. Andrew Kambugu: AbbVie, MSD
• Dr. Patrick Li: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceutica, Merck Sharp & Dohme, ViiV Healthcare
• Dr. Jürgen Rockstroh: Abbott, AbbVie, BI, Bionor, BMS, Janssen, Merck, Novartis, Pfizer, Roche, Tibotec, Vertex, ViiV
5
Housekeeping
• Please switch mobile phones and pagers to vibrate
• Kindly do not use flash photography
• To ask a question at the end of the symposium:
– Please fill in question card and hand to a member of staff
• Please complete the evaluation form at the end of the symposiumand hand it to a member of staff as you leave
